Effect of EPA/DHA combination therapy on LDL particle size in patients with hyperlipidemia and type 2 diabetes taking HMG-CoA reductive enzyme inhibitors and DPP-4 inhibitors.
Phase of Trial: Phase II
Latest Information Update: 16 May 2017
Price : $35 *
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- 12 May 2017 Status changed from active, no longer recruiting to completed.
- 25 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 02 Jul 2014 New trial record